GlassScriptPhysician profile
Hanish K Singh
NPI 1962736785
$10,541.52
in general payments reported to CMS, 2019-2025
25 companies · $4,384 in 2025
The $4,384 reported for 2025 was more than what 92% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $843 · 2020: $1,626 · 2021: $618 · 2022: $391 · 2023: $1,112 · 2024: $1,567 · 2025: $4,384.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,934 · Food and Beverage: $3,130.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,933.98 |
| Food and Beverage | $3,129.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,330.31 | 2020-2025 | General - Therapies, Wavewriter Alpha Prime 16 |
| Nevro Corp. | $1,445.73 | 2020-2024 | Senza |
| Globus Medical, INC. | $1,231.30 | 2025 | Senza |
| Curonix LLC | $1,192.24 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Abbott Laboratories | $1,044.94 | 2020-2025 | Proclaim |
| Medtronic USA, INC. | $840.93 | 2019-2020 | |
| Nalu Medical, INC. | $800.80 | 2025 | Nalu Neurostimulation System |
| Bioventus LLC | $726.37 | 2020-2023 | Stimrouter Implantable Kit, Durolane |
| Abbvie INC. | $263.41 | 2022-2025 | Ubrelvy, Botox, Qulipta |
| Spr Therapeutics, INC | $184.96 | 2020-2021 | |
| Medtronic, INC. | $71.93 | 2025 | Synchromedii, Intellis Adaptivestim |
| Dynasplint Systems INC. | $69.04 | 2022 | |
| Amgen INC. | $46.21 | 2022-2023 | Prolia, Evenity |
| Stryker Corporation | $34.56 | 2020-2024 | Gamma, T2 Alpha |
| Lilly USA, LLC | $34.36 | 2020-2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biodelivery Sciences International, INC. | $32.26 | 2020 | |
| Collegium Pharmaceutical, INC. | $29.99 | 2021 | |
| Lundbeck LLC | $29.46 | 2023 | Vyepti |
| Si-Bone, INC. | $24.04 | 2025 | |
| Baxter Healthcare | $22.98 | 2025 | Floseal |
| Hikma Pharmaceuticals USA | $21.00 | 2022 | |
| Allergan, INC. | $20.30 | 2021 | |
| Virtus Pharmaceuticals LLC | $15.19 | 2020 | |
| Relievant Medsystems, INC. | $14.90 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $14.31 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hanish Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.